Opinion

Podcast

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Author(s):

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

Debra Patt, MD, PhD, MBA, executive vice president of policy and strategic initiatives and director of public policy at Texas Oncology, joins hosts Emeline Aviki, MB, MBA, medical director and attending surgeon at NYU Langone Perlmutter Cancer Center, and Stephen, MD, MBA, chief medical officer at Tennessee Oncology, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

Patt is a policy and physician expert, breast cancer specialist, and board member of the Community Oncology Alliance and American Society of Clinical Oncology. Her in-depth conversation with Aviki and Schleicher addresses several important issues currently affecting high-quality oncology care: most important, the current drug shortage, and the economics that made it a problem, innovative ways to fix it, and economic solutions to prevent it from perpetuating.

They also discuss the instability of drug pricing—wholesale acquisition cost vs average sales price—the relationship between cancer and aging, pharmacy benefits managers and how they have affected the price of cancer care, and facilitating meaningful change for patients.

For audio only:

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Parth Rali, MD
IMS Recap
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
April Armstrong, MD, MPH, chief of dermatology, UCLA
Javed Butler, MD, MPH, MBA
Screenshot during an interview with Aaron Adkisson, PharmD
Kirollos Hanna, PharmD
Binod Dhakal, MD.
Stuart Staggs
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo